[1] Two ACT companies have been given the Accelerating Commercialisation program’s first grants.
[2] Providing pathology testing services, Australian company MyHealthTest earned a maximum grant amount of $1 million.
[3] Interfere X Communications Pty Ltd. got a grant funding of $325,000 that will be utilised for their cutting-edge software product, RANifex.
[Source] Australian Information Technology News – First Accelerating Commercialisation grants awarded